Literature DB >> 34293937

Overexpression of HOXA10 promotes the growth and metastasis of nasopharyngeal carcinoma.

Dan Gong1,2, Hui Zhu3, Lei Zeng1,2, Ronghuan Hu1,2, Jiali Hu1,2, Jianwu Ding1,2.   

Abstract

Deregulation of HOX transcription factor family has frequently been observed in multiple human cancers; however, their role in nasopharyngeal carcinoma remains largely unclear. In the present study, we found that HOX gene family is consistently upregulated in nasopharyngeal carcinoma and identified HOXA10 as one of the mostly upregulated HOX genes. Importantly, we show that HOXA10 overexpression is associated with transcriptional activation of multiple oncogenes essential for nasopharyngeal carcinoma carcinogenesis, including S-phase kinase-associated protein 2 (SKP2), calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2), and matrix metalloproteinase 1 (MMP1). Mechanistically, the overexpression of SKP2 induces the degradation of cell cycle inhibitor p27, leading to rapid cell cycle progression and cell proliferation. The overexpression of CAMKK2 is associated with enhanced mTOR signaling activity to meet the increased demand for proteins synthesis in rapid growing nasopharyngeal carcinoma cells. Moreover, MMP1 overexpression facilitates nasopharyngeal carcinoma cell migration and invasion and contributes to cancer metastasis and progression. We thus concluded that HOXA10 overexpression promotes the growth and metastasis of nasopharyngeal carcinoma by transcriptionally activating various oncogenic pathways.

Entities:  

Keywords:  CAMKK2; HOX genes; HOXA10; MMP1; Nasopharyngeal carcinoma; SKP2

Mesh:

Substances:

Year:  2021        PMID: 34293937      PMCID: PMC8649939          DOI: 10.1177/15353702211030854

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  33 in total

1.  HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.

Authors:  Xinyan Wu; Hexin Chen; Belinda Parker; Ethel Rubin; Tao Zhu; Ji Shin Lee; Pedram Argani; Saraswati Sukumar
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

2.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Authors:  Scott A Armstrong; Jane E Staunton; Lewis B Silverman; Rob Pieters; Monique L den Boer; Mark D Minden; Stephen E Sallan; Eric S Lander; Todd R Golub; Stanley J Korsmeyer
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

Review 3.  The mTOR pathway in the control of protein synthesis.

Authors:  Xuemin Wang; Christopher G Proud
Journal:  Physiology (Bethesda)       Date:  2006-10

4.  HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma.

Authors:  Manoela Carrera; Carolina C Bitu; Carine Ervolino de Oliveira; Nilva K Cervigne; Edgard Graner; Aki Manninen; Tuula Salo; Ricardo D Coletta
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 5.  The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft.

Authors:  Kathrina L Marcelo; Anthony R Means; Brian York
Journal:  Trends Endocrinol Metab       Date:  2016-07-20       Impact factor: 12.015

6.  A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

Authors:  Xiao-Jun Ma; Zuncai Wang; Paula D Ryan; Steven J Isakoff; Anne Barmettler; Andrew Fuller; Beth Muir; Gayatry Mohapatra; Ranelle Salunga; J Todd Tuggle; Yen Tran; Diem Tran; Ana Tassin; Paul Amon; Wilson Wang; Wei Wang; Edward Enright; Kimberly Stecker; Eden Estepa-Sabal; Barbara Smith; Jerry Younger; Ulysses Balis; James Michaelson; Atul Bhan; Karleen Habin; Thomas M Baer; Joan Brugge; Daniel A Haber; Mark G Erlander; Dennis C Sgroi
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

7.  Upregulation HOXA10 homeobox gene in endometrial cancer: role in cell cycle regulation.

Authors:  Lin Zhang; Yicong Wan; Yi Jiang; Jingjing Ma; Jinsong Liu; Weiwei Tang; Xinru Wang; Wenjun Cheng
Journal:  Med Oncol       Date:  2014-06-19       Impact factor: 3.064

8.  HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer.

Authors:  Paloma Ordóñez-Morán; Caroline Dafflon; Masamichi Imajo; Eisuke Nishida; Joerg Huelsken
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

9.  HOXA7 plays a critical role in metastasis of liver cancer associated with activation of Snail.

Authors:  Bo Tang; Guangying Qi; Xiaoyu Sun; Fang Tang; Shengguang Yuan; Zhenran Wang; Xingsi Liang; Bo Li; Shuiping Yu; Jie Liu; Qi Huang; Yangchao Wei; Run Zhai; Biao Lei; Xinjin Guo; Songqing He
Journal:  Mol Cancer       Date:  2016-09-06       Impact factor: 27.401

10.  HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer.

Authors:  Chenlong Song; Yang Han; Huan Luo; Zhiwei Qin; Zhengqian Chen; Yuan Liu; Su Lu; Huimin Sun; Chongzhi Zhou
Journal:  Cancer Med       Date:  2019-07-30       Impact factor: 4.452

View more
  2 in total

1.  Neferine Exerts Ferroptosis-Inducing Effect and Antitumor Effect on Thyroid Cancer through Nrf2/HO-1/NQO1 Inhibition.

Authors:  Shujing Li; Yanyan Zhang; Jin Zhang; Bo Yu; Weiran Wang; Baosong Jia; Jingtao Chang; Jing Liu
Journal:  J Oncol       Date:  2022-06-27       Impact factor: 4.501

2.  Construction of lncRNA and mRNA co-expression network associated with nasopharyngeal carcinoma progression.

Authors:  Xu Lu; Xing Chen; Xinke Wang; Jing Qing; Ji Li; Yunyun Pan
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.